Abstract:Ethnopharmacological relevance: Morus alba L. is a widespread plant that has long been considered to have remarkable medical values, including anti-inflammation in Traditional Chinese Medicine (TCM). The components of Morus Alba L. constituents have been extensively studied and have been shown to have high prospects for cancer therapy. However, limited investigations have been done on the bioactive compounds in Morus alba L. Aim of the study: This study aimed to systematically examine the anticancer properties of 28 commercially available compounds from Morus alba L. against melanoma cells in vitro. Additionally, the anticancer mechanisms of the bioactive compound exhibiting the most significant potential were further studied. Materials and methods: The anti-proliferative effects of Morus alba L.-derived compounds on melanoma cells were determined by colony formation assays. Their effects on cell viability and apoptosis were determined using the CCK8 assay and flow cytometry, respectively. The binding affinity of identified Morus alba L. compounds with anticancer activities towards melanoma targets was analyzed via molecular docking. The molecular mechanism of Sanggenon C was explored using soft agar assays, EdU incorporation assays, flow cytometry, western blotting, transcriptome analysis, and xenograft assays. Results: Based on colony formation assays, 11 compounds at 20 mu M significantly inhibited colony growth on a panel of melanoma cells. These compounds displayed IC50 values (half maximal inhibitory concentrations) ranging from 5 mu M to 30 mu M. Importantly, six compounds were identified as novel anti-melanoma agents, including Sanggenon C, 3 '-Geranyl-3-prenyl-2 ',4 ',5,7-tetrahydroxyflavone, Moracin P, Moracin O, Kuwanon A, and Kuwanon E. Among them, Sanggenon C showed the most potent effects, with an IC50 of about 5 mu M, significantly reducing proliferation and inducing apoptosis in melanoma cells. Based on the xenograft model assay, Sanggenon C significantly inhibited melanoma cell proliferation in vivo. Sanggenon C triggered ER stress in a dose-dependent manner, which further disrupted cellular calcium ion (Ca2+) homeostasis. The Ca2+ chelator BAPTA partially restored cell apoptosis induced by Sanggenon C, confirming that Ca2+ signaling contributed to the anticancer activity of Sanggenon C against melanoma. Conclusions: In our study, 11 compounds demonstrated anti-melanoma properties. Notably, Sanggenon C was found to promote apoptosis by disrupting the intracellular calcium homeostasis in melanoma cells. This study provides valuable information for the future development of novel cancer therapeutic agents from Morus alba L.

Compounds Inhibiting Hyperglycemia and Cancer Cell Proliferation from Morus Alba L

Bioassay-guided screening and isolation of α-glucosidase and tyrosinase inhibitors from leaves of Morus alba

In vivo hypoglycemic effects of phenolics from the root bark of Morus alba

Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells.

Screening of Anti-Melanoma Compounds from Morus Alba L.: Sanggenon C Promotes Melanoma Cell Apoptosis by Disrupting Intracellular Ca2+ Homeostasis.

Isoprenylated Flavonoids and 2-Arylbenzofurans from the Root Bark of Morus alba L. and Their Cytotoxic Activity against HGC27 Cancer Cells

A New Flavanone Glycoside with Anti-proliferation Activity from the Root Bark of Morus Alba

Screening of anti-melanoma compounds from Morus alba L.: Sanggenon C promotes melanoma cell apoptosis by disrupting intracellular Ca 2+ homeostasis

Morusinol Extracted from Morus Alba Inhibits Cell Proliferation and Induces Autophagy Via FOXO3a Nuclear Accumulation-Mediated Cholesterol Biosynthesis Obstruction in Colorectal Cancer.

α-Glucosidase inhibitors and antioxidants from root bark of Morus alba

Two Novel Compounds from the Root Bark of Morus Alba L.

Inhibition Mechanism of Components Isolated from Morus alba Branches on Diabetes and Diabetic Complications via Experimental and Molecular Docking Analyses

Bioassay-guided discovery and identification of new potent α-glucosidase inhibitors from Morus alba L. and the interaction mechanism

Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition

LC-MS Metabolite Profiling and the Hypoglycemic Activity of Morus alba L. Extracts

Phenolic constituents from the root bark of Morus alba L. and their cardioprotective activity in vitro

In vitro and in silico studies reveal antidiabetic property of arylbenzofurans from the root bark of Morus mesozygia Stapf

Gastrointestinal Cancer Therapeutics via Triggering Unfolded Protein Response and Endoplasmic Reticulum Stress by 2-Arylbenzofuran

Antitumor Effect of Morusin via G1 Arrest and Antiglycolysis by AMPK Activation in Hepatocellular Cancer

Novel active compounds and the anti-diabetic mechanism of mulberry leaves

Anti-Tumor Effect of Morusin from the Branch Bark of Cultivated Mulberry in Bel-7402 Cells Via the Mapk Pathway